CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerbaul, F.
Right arrow Articles by Aubert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerbaul, F.
Right arrow Articles by Aubert, M.
Canadian Journal of Anesthesia 48:760-767 (2001)
© Canadian Anesthesiologists' Society, 2001

General Anesthesia

Sub-MAC concentrations of desflurane do not inhibit hypoxic pulmonary vasoconstriction in anesthetized piglets

[La vasoconstriction pulmonaire hypoxique n'est pas inhibée par des concentrations de desflurane inférieures à la CAM chez des porcelets anesthésiés]

F. Kerbaul, MD*, C. Guidon, MD*, J. Stephanazzi, MD{dagger}, M. Bellezza, MD*, P. Le Dantec , MD{ddagger}, T. Longeon§ and M. Aubert, MD§

* From the Departments of Anesthésie-Réanimation Adulte, Groupe Hospitalier de La Timone, Marseilles;
{dagger} Anesthésie-Réanimation, Hôpital Percy, Paris;
{ddagger} Anesthésie-Réanimation, Hôpital Sainte Anne, Toulon Armées; and
§ Anesthésie-Réanimation, Hôpital d'Instruction des Armées Laveran, Marseilles, France.

Address correspondence to: Dr. François Kerbaul, Département d'Anesthésie-Réanimation Adulte, Groupe Hospitalier de La Timone, 264 rue Saint Pierre, 13385 Marseille Cedex 05, France. Phone: 04-91-38-57-91; Fax: 04-91-38-58-50; E-mail: fkerbaul{at}yahoo.fr Institution: IMTSSA, Parc du Pharo, 13998 Marseille Armées.


    Abstract
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
Purpose: In vitro, halogenated agents reduce the pulmonary vasoconstrictor response to alveolar hypoxia in isolated perfused lungs. However, studies in intact animals have been less convincing. The aim of the present study was to assess the effect of sub-MAC concentrations of desflurane on hypoxic pulmonary vasoconstriction (HPV) in anesthetized piglets using the pressure/cardiac output relationship (P/Q).

Methods: Eleven large white piglets were anesthetized and ventilated mechanically, alternatively in hyperoxia (FIO2=0.4) and in hypoxia (FIO2=0.12). Multipoint plots of pulmonary arterial pressure (PAP), or differences between PAP and left atrial pressure (LAP) against Q were generated by gradual inflation of a balloon advanced into the inferior vena cava. P/Q relationships were established in hyperoxia and in hypoxia at baseline, and then with gradual concentrations of desflurane.

Results: In hypoxia, pressure gradients (PAP-LAP) increased significantly at every level of Q, demonstrating active pulmonary vasoconstriction. Desflurane did not affect these P/Q relationships either in hyperoxia, or in hypoxia, when compared with baseline.

Conclusion: Desflurane at a clinically relevant dose has no significant effect on HPV in anesthetized piglets.


    Introduction
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
PULMONARY vasoconstriction in response to acute hypoxia helps maintain arterial oxygen tension.1 Impairment of this mechanism by inhalational anesthetic agents has been implicated in hypoxemia during anesthesia.2 In vitro studies have demonstrated that halothane, enflurane, isoflurane and sevoflurane inhibit hypoxic pulmonary vasoconstriction (HPV).3,4 However halogenated agents seem to be less effective pulmonary vasodilators in in vivo lung lobes.57

Desflurane is a recently introduced inhalational anesthetic. Its effects on HPV have been the focus of a few studies. In vitro experiments using constant-flow perfused rabbit lung confirmed concentration-dependent inhibition of vasoconstriction by desflurane.8 Another study, in intact chronically instrumented animals, showed that desflurane did not inhibit HPV.9

The present study was designed to assess the effect of two sub-MAC concentrations of desflurane on HPV in intact anesthetized piglets. Piglets where chosen as the study model because of their strong pulmonary vasoconstriction in response to hypoxia,10 and because their postnatal morphometric pulmonary development closely parallels that of humans.11 Pulmonary hemodynamics were evaluated by multipoint pulmonary vascular pressures –flow plots (P/Q plots) which provide a quantitative characterization of the pulmonary vascular pressure (P)-cardiac output (Q) relationship.6,7 Previous experiments have demonstrated that these plots are linear in intact anesthetized piglets.12


    Material and methods
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
All experimental procedures were reviewed and approved by the Animal Ethics Committee of La Timone Medical School in Marseille. All procedures were compliant with the Guiding Principles in the Care and Use of Animals of the American Physiological Society.

Animal preparation
After a 12-hr fasting period with free access to water, 11 large white piglets (22–30 kg, mean 24 kg) were premedicated with ketamine (20 mg•kg–1 im), midazolam (0.1 mg•kg–1 im), and atropine (0.25 mg im), and placed in the supine position. Anesthesia was induced with midazolam (0.1 mg•kg–1 iv) fentanyl (2 µg•kg–1 iv) and maintained with iv infusions of fentanyl (20 µg•kg–1•hr–1) and midazolam (0.1 mg•kg–1•hr–1). Muscle paralysis was achieved with vecuronium bromide 1 mg•kg–1 iv and maintained with an infusion of vecuronium bromide (2 mg•kg–1•hr–1) after tracheostomy had been performed. Lungs were ventilated mechanically via a n6 cuffed tracheostomy tube (Tracheosoft LanzTM 101-70 ID 6.0 Malindkrodt Medical, Athlone Ireland) with a Servo ventilator B 900 (Siemens, Elema, Sweden) initially set to deliver a FIO2 of 0.4, a tidal volume of 12–15 mL•kg–1 and a respiratory rate adjusted to maintain an arterial PaCO2 between 35 and 40 mmHg. No positive end-expiratory pressure was used. Desflurane was administered using a vaporizer adapted to the ventilator. Inspired and expired fractions of O2, CO2 and desflurane were measured using an infrared spectrophotometer Ultima IITM (Datex, Helsinki, Finland).

Throughout the experiment, 0.9% sodium chloride was infused in the left internal jugular vein at a rate of 4 mL•kg–1•hr–1. Temperature was maintained at 38–39°C using an electrical heating pad. Metabolic acidosis, when present, was corrected by slow infusion of triaminolacetate (THAMTM, Roger Bellon Laboratories, France). All catheters were inserted through peripheral cut-downs.

A thermistor-tipped pulmonary artery catheter (93A-131-7F, Edwards Laboratories, Santa Anna CA, USA) was inserted in the right internal jugular vein, positioned with reference to the right atrium and used to measure right atrial pressure (RAP), mean pulmonary arterial pressure (PAP) and mean capillary wedge pressure (PCWP). It was also used to measure central core temperature and perform mixed venous blood sampling. A polyethylene catheter was placed in the abdominal aorta via the right femoral artery for systemic arterial pressure (SAP) measurements and arterial blood sampling. A balloon catheter (RedigardTM, 9F 40 mL, St Jude Medical Inc., Chelmsford MA, USA ) was placed in the inferior vena cava (IVC) through a right femoral venotomy. Inflation of this balloon produced a graduable decrease in cardiac output by reducing venous return.

A left thoracotomy was performed to place, into the left atrium, a polyethylene catheter (Liddle LAP 17 G 50.6 cm, Research Medical Inc. Salt Lake City UT, USA) to monitor left atrial pressure (LAP). The thoracotomy was closed hermetically and a chest tube (Argyle 24) inserted in the pleural space, connected to a vacuum-pump and then to a water seal as soon as vacuum was achieved. Thrombus formation along the catheters was prevented by heparin sodium (100 iu•kg–1 iv) just before insertion and a continuous infusion of 100 iu•kg–1•hr–1.

Measures
Pulmonary, cardiac and systemic pressures were measured using disposable transducers (Pressure monitoring kit Baxter S.A., Maurepas, France) connected to a multichannel monitor (MerlinTM, Hewlett-Packard Inc., Palo Alto CA, USA). Zero reference was located at midchest, and readings were taken at the end of expiration. Heart rate (HR) was determined continuously by the same monitor with three electrocardiographic leads. Cardiac output was measured rapidly at the end of expiration by thermodilution using injections of 5 mL of 0.9 % sodium chloride at 0°C. Cardiac output values correspond to the mean of at least three measurements after elimination of readings 10% higher or lower than the previous value. Hemodynamic data were sampled every 20 sec, digitized and stored on the hard disk of a personal IBM PC/AT (Hewlett Packard Vectra 386 DX 33 and Hewlett Packard software). Arterial and mixed venous pH, PCO2, PO2 were measured immediately after drawing the samples using an automated analyzer (ABL 500, Radiometer, Copenhagen, Denmark); all blood gases values were corrected according to central temperature.

Protocol
After ensuring steady-state conditions for ten minutes at an FIO2 of 0.4 (stable SAP, PAP, LAP, Q, end-tidal CO2, and HR), a first four-point P/Q plot was generated in 20 min: the first point corresponding to basal cardiac output followed by one point for each incremental inflation of the vena cava balloon (three points). Construction of each point of the plot lasted five minutes. Then, a similar plot was constructed at an FIO2 of 0.12 when PaO2 reached 40–50 mmHg. Previously reported stimulus-response curves for HPV in intact anesthetized ventilated piglets show that the whole-lung hypoxic pressor response is undetectable if FIO2 is >0.3 and maximal when FIO2 is 0.12.13 Similar plots were generated at FIO2 0.4 and at FIO2 0.12 with respectively 2.5% and 5% end-tidal desflurane concentrations. At each step of the study and for each level of Q, measures of hemodynamic parameters (SAP, LAP, RAP, PCWP, PAP, HR), arterial and mixed venous blood gases were performed. Repeated exposure to hypoxia was performed to make sure that the magnitude of HPV was constant throughout the experiment. Animals were humanely sacrified at the end of the protocol by iv infusions of midazolam (20 mg), fentanyl (500 µg) and KCl 10% (3 g).

Statistical analysis
Visual inspection of the individual PAP/Q, PAP-LAP/Q and PAP-PCWP/Q plots showed them to be linear, and thus a linear regression analysis (least square method) was used to compute slopes. Q was considered to be the independent variable and pressure the dependent variable. To obtain composite P/Q plots, pressures interpolated from the regression analysis from individual piglets were averaged at 0.5 L•min–1 intervals of Q from 1.5 to 3.5 L•min–1. The blood gases and hemodynamic data were analyzed by analysis of variance for serial measurements. When the significance of a factor was P <0.05, a Bonferroni post-hoc test was performed to compare specific situations. Comparison of slopes of composites P/Q plots were assessed by Student's t test. Data are presented as means ± SD. All analyses were performed with Statview 4TM software Abacus concept) on a MacintoshTM Power PC 6200/75 personal computer.


    Results
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
Manipulation of cardiac output
Stepwise inflations of the IVC balloon induced variations of Q. Mean values ranged from 1.6 to 3.5 L•min–1 (Table IGo). The PAP/Q, PAP-LAP/Q and PAP-PCWP/Q relationships were linear in all experimental conditions (Table IIGo). Blood gases mainly changed by a decrease in mixed venous PO2 at the lowest Q (Table IIIGo).


View this table:
[in this window]
[in a new window]
 
TABLE I Effects of gradual concentrations of desflurane on hemodynamic data
 

View this table:
[in this window]
[in a new window]
 
TABLE II Slopes and correlation coefficients of the composites P/Q plots
 

View this table:
[in this window]
[in a new window]
 
TABLE III Effects of desflurane
 
Baseline values in hyperoxia and hypoxia
Hypoxia markedly decreased arterial and mixed venous PO2 with no change in pH and PaCO2 (Table IIGo). SAP, LAP, RAP and PCWP were the same in hypoxic and hyperoxic conditions. Over the full range of Q studied, hypoxia increased PAP (P <0.01), while it induced a significant increase in HR for the lowest Q. The main sign of hypoxic pressor response was a significant increase in the slopes of PAP/Q, PAP-LAP/Q and PAP-PCWP/Q relationships (Table IIGo).

Desflurane in hyperoxia
End tidal 2.5% and 5% desflurane significantly increased HR and significantly reduced SAP compared with baseline (P <0.05), whereas PAP, LAP, RAP, PCWP were unchanged. At the lowest Q, desflurane decreased SAP significantly when compared to baseline (P <0.05).

Desflurane in hypoxia
At the highest Q, end tidal 2.5% and 5% desflurane increased HR and significantly reduced SAP compared with baseline. PAP, LAP and PCWP were unchanged (Table IGo). At lowest Q, desflurane significantly reduced SAP. HPV was not inhibited by 2.5% and 5% end tidal desflurane (Figure 2Go).



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 2 Extrapolated plots of PAP - PCWP vs cardiac output (Q) with 2.5% end tidal desflurane in hyperoxia (open squares) and in hypoxia (closed squares), with 5% end tidal desflurane in hyperoxia (open circles) and in hypoxia (closed circles). Values are means ± SEM, n=11 piglets.

 
Desflurane had no effect on PaO2, pHa, PvO2, PaCO2 at highest Q. At the lowest Q, there was a mild decrease of PvO2 compared with the highest Q.


    Discussion
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
The present study was designed to assess the effect of two sub-MAC concentrations of desflurane on HPV in intact piglets. P/Q plots were generated in 11 piglets anesthetized with midazolam, fentanyl and ventilated mechanically. Desflurane at a clinically relevant dose induced a marked systemic vasodilation (decrease in SAP with an unchanged Q), but HPV was unaffected by this anesthetic agent. The end tidal concentrations of desflurane studied are equivalent to 0.3 and 0.6 MAC in pigs.13 Higher concentrations are required to induce a relevant effect on HPV in isolated lung.8 This concentration was chosen because a higher concentration (1 MAC) induced a vigorous systemic hypotension in piglets. Also, it is equivalent to that used in the clinical settings when in combination with opiates.14 Opioids are known to reduce the anesthetic requirement (determined by reduction of MAC) in both animals15 and humans. One study showed a reduction in the MAC of desflurane of approximately 49% after a single dose of fentanyl (3 µg•kg–1 iv).14

A previous in vitro study had demonstrated that desflurane inhibits HPV in a dose related manner, in constant flow perfused rabbit lung.8 To our knowledge, only one study has assessed the effects of desflurane on HPV in chronically instrumented and unsedated dogs,9 and no previous experiment had been performed in anesthetized piglets.

The technique used to assess pharmacological and physiological variations in pulmonary vasomotor tone involved generation of multipoint P/Q plots. This technique was developped by Lodato et al. in conscious dogs, at two different inspired oxygen concentrations.12 The IVC occlusion technique by incremental inflation of a balloon catheter produced a titratable decrease in Q. P/Q plots were then generated. The P/Q relationship allows discrimination of vasoactive from passive mechanical effects on the pulmonary circulation. This technique is more relevant than the use of calculated pulmonary vascular resistance (PVR), which does not take in consideration how this resistance varies with Q. However it has a number of limitations including systemic hypotension, changes in blood gases and changes in zonal conditions of the lung. This technique has already been used in mammals to test the effects of anesthetics5 and of physiologic or metabolic manipulations on HPV.16,17 The P/Q plots in our piglets were linear in all experimental conditions, in keeping with previous studies in intact anaesthetized5,6 or unsedated animals.12

HPV shows a large inter-individual and inter-species variability.18 In our experiment, we chose 12-week-old piglets because of their strong pressor response to hypoxia10 which is greater than that of other mammals and because their postnatal morphometric pulmonary development closely parallels that of humans.11

A number of factors may alter pulmonary vascular pressor response to hypoxia in animals. Increasing LAP can reduce HPV in anesthetized animals. This suggests that the whole pulmonary vasculature does not behave as a Starling resistor either in hyperoxia or in hypoxia.17 In our piglets, LAP remained unchanged throughout study, and so could not have modified pulmonary vascular response to hypoxia.

Although pressor response is usually dependent on PaO2, changes in mixed venous PvO2 can be important during hypoxia, and subsequently modify the magnitude of HPV.19 In our study, hypoxia and low Q led to a marked decrease in PvO2 in both cases. This decrease could have enhanced HPV.

Pressor responses can be altered by changes in arterial pH and PaCO2.20 In anesthetized dogs, marked alkalosis induced by artificial hyperventilation during hypoxia has been shown to reduce PAP.20 In our study, arterial pH and PaCO2 were kept constant at all levels of Q. Therefore, variations of pH and PaCO2 were unlikely to have affected HPV.

Finally, reduction of Q, as was performed in our experiment, activates the arterial baroreceptor reflex. Carotid sinus baroreceptor reflex has been shown to have a direct control on the entire systemic and PAP-flow relationships in anesthetized dogs.21 In intact conscious dogs, circulatory hypotension resulted in active pulmonary vasoconstriction, primarily mediated by sympathetic 1adrenoreceptor activation.22 In our study, at baseline, baroreceptor reflex was not activated by lowering Q, as suggested by lower PAP at lowest Q in both hyperoxia and hypoxia.

As in previous experiments with other inhaled anesthetics in intact mammals, desflurane induced only systemic vasodilation and had no significant effect on HPV, when used at sub-MAC concentrations. Investigations assessing the effects of halogenated agents on HPV have provided different results, depending on the experimental model. Studies on isolated perfused lungs showed an inhibition of HPV by inhaled agents.3,4,8 Conversely, experiments with intact mammals showed either an inhibition23 or no significant effect.6,9,24

Associated iv anesthetics
This experiment required general anesthesia and mechanical ventilation. These anesthetic conditions resemble the clinical situation, where desflurane is administered with fentanyl.14 This opiate has no recognized effect on pulmonary vascular tone.25 In our study, we chose an infusion of midazolam rather than pentobarbitone since the former has no demonstrated effect on pulmonary vascular tone.25,26

Mechanical ventilation
Intermittent positive pressure ventilation can modify pulmonary circulation by different mechanisms such as a direct compression of alveolar vessels or increased lung volumes.27 This could explain different results between mechanically ventilated and unsedated intact animals.

In our experiment, we measured pulmonary vascular pressures at the end of expiration when pleural pressure is supposed to be the lowest. However, effects of mechanical ventilation on pulmonary vascular tone cannot be excluded.

Site of action of hypoxia
This site could be different depending on species. In dogs, HPV is thought to occur mainly in pulmonary arteries,28 whereas in pigs, capillaries may be the major site of vasoconstriction.29

Action of the sympathetic nervous system
In anesthetized dogs, chemical sympathectomy or chemodenervation increased PAP at all levels of Q studied both in hypoxia and in hyperoxia.30 The effect of the sympathetic nervous system in hyperoxic as well as in hypoxic healthy mammals' lungs seems to be a reduction in pulmonary vascular tone.

In our study, administration of desflurane in both hyperoxia and in hypoxia induced a significant increase of HR at highest Q wich was associated with lower systemic arterial pressure. Thus, desflurane could have partially altered the baroreflex. The effect of desflurane on HPV in the intact animal is therefore more apparent than in isolated lung, where the autonomic nervous system is not effective. This could explain discrepancies between in vitro and in vivo studies on desflurane.

In summary, this experiment assessed the effect of two sub-MAC concentrations of desflurane on HPV in intact, anesthetized, mechanically ventilated piglets. Hypoxia resulted in a significant increase in pressure gradients (PAP-LAP) and (PAP-PCWP), due to active pulmonary vasoconstriction. Desflurane did not influence HPV as evaluated by the pulmonary vascular pressure/Q relationship. These conclusions are different from those described in in vitro experiments, but they are in agreement with previous in vivo studies on desflurane9 and sevoflurane.6



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 1 Extrapolated plots of PAP vs cardiac output (Q) with 2.5% end tidal desflurane in hyperoxia (open squares) and in hypoxia (closed squares), with 5% end tidal desflurane in hyperoxia (open circles) and in hypoxia (closed circles). Values are means ± SEM, n=11 piglets.

 


View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 3 Extrapolated plots of PAP - LAP vs cardiac output (Q) with 2.5% end tidal desflurane in hyperoxia (open squares) and in hypoxia (closed squares), with 5% end tidal desflurane in hyperoxia (open circles) and in hypoxia (closed circles). Values are means ± SEM, n=11 piglets.

 

    Acknowledgments
 
To Peter Mac Cavana and Patrick Bartarès for their active contribution in this study.

Revision received April 18, 2001. Accepted for publication February 27, 2001.


    References
 TOP
 Abstract
 Introduction
 Material and methods
 Results
 Discussion
 References
 
1 Cutaia M, Rounds S. Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanism, and clinical relevance. Chest 1990; 97: 706–18.[Free Full Text]

2 Pavlin EG. Respiratory pharmacology of inhaled anesthetic agents. In: Anesthesia. Miller RD (Ed.). New York: Churchill Livingstone, 1981: 349–82.

3 Marshall C, Lindgren L, Marshall BE. Effects of halothane, enflurane, and isoflurane on hypoxic pulmonary vasoconstriction in rat lungs in vitro. Anesthesiology 1984; 60: 304–8.[Medline]

4 Ishibe Y, Gui X, Uno H, Shiokawa Y, Umeda T, Suekane K. Effect of sevoflurane on hypoxic pulmonary vasoconstriction in the perfused rabbit lung. Anesthesiology 1993; 79: 1348–53.[Medline]

5 Ewalenko P, Stephanidis C, Holoye A, Brimioulle S, Naeije R. Pulmonary vascular impedance vs. resistance in hypoxic and hyperoxic dogs: effects of propofol and isoflurane. J Appl Physiol 1993; 74: 2188–93.[Abstract/Free Full Text]

6 Kerbaul F, Bellezza M, Guidon C, et al. Effects of sevoflurane on hypoxic pulmonary vasoconstriction in anaesthetized piglets. Br J Anaesth 2000; 85: 440–5.[Abstract/Free Full Text]

7 Domino KB, Borowec L, Alexander CM, et al. Influence of isoflurane on hypoxic pulmonary vasoconstriction in dogs. Anesthesiology 1986; 64: 423–9.[Medline]

8 Loer SA, Scheeren TWL, Tarnow J. Desflurane inhibits hypoxic pulmonary vasoconstriction in isolated rabbit lung. Anesthesiology 1995; 83: 552–6.[Medline]

9 Lesitsky MA, Davis S, Murray PA. Preservation of hypoxic pulmonary vasoconstriction during sevoflurane and desflurane anesthesia compared to the conscious state in chronically instrumented dogs. Anesthesiology 1998; 89: 1501–8.[Medline]

10 Tucker A, Mac Murtry IF, Reeves JT, Alexander AF, Will DH, Grover RF. Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude. Am J Physiol 1975; 228: 762–7.[Abstract/Free Full Text]

11 Rendas A, Branthwaite M, Reid L. Growth of pulmonary circulation in normal pig – structural analysis and cardiopulmonary function. J Appl Physiol 1978; 45: 806–17.[Abstract/Free Full Text]

12 Lodato RF, Michael JR, Murray PA. Multipoint pulmonary vascular pressure-cardiac output plots in conscious dogs. Am J Physiol 1985; 249: H351–7.

13 Weiskopf RB, Holmes MA, Rampil IJ, et al. Cardiovascular safety and actions of high concentrations of I- 653 and isoflurane in swine. Anesthesiology 1989; 70: 793–8.[Medline]

14 Sebel PS, Glass PSA, Fletcher JE, Murphy MR, Gallagher C, Quill T. Reduction of the MAC of desflurane with fentanyl. Anesthesiology 1992; 76: 52–9.[Medline]

15 Hecker BR, Lake CL, DiFazio CA, Moscicki JC, Engle JS. The decrease of the minimum alveolar anesthetic concentration produced by sufentanil in rats. Anesth Analg 1983; 62: 987–90.[Abstract/Free Full Text]

16 De Canniere D, Stefanidis C, Hallemans R, Delcroix M, Brimioulle S, Naeije R. Stimulus-response curves for hypoxic pulmonary vasoconstriction in piglets. Cardiovasc Res 1992; 26: 944–9.[Medline]

17 Lejeune P, De Smet J-M, De Francquen P, et al. Inhibition of hypoxic pulmonary vasoconstriction by increased left atrial pressure in dogs. Am J Physiol 1990; 259: H93–100.[Abstract/Free Full Text]

18 Grover RF, Vogel JHK, Averill KH, Blount SG Jr. Pulmonary hypertension: individual and species variability relative to vascular reactivity. Am Heart J 1966; 66: 1–3.

19 Hughes JD, Rubin LJ. Relation between mixed venous oxygen tension and pulmonary vascular tone during normoxic, hyperoxic and hypoxic ventilation in dogs. Am J Cardiol 1984; 54: 1118–23.[Medline]

20 Loeppky JA, Scotto P, Riedel CE, Roach RC, Chick TW. Effects of acid-base status on acute hypoxic pulmonary vasoconstriction and gas exchange. J Appl Physiol 1992; 72: 1787–97.[Abstract/Free Full Text]

21 Shoukas AA, Brunner MJ, Frankle AE, Greene AS, Kallman CH. Carotid sinus baroreceptor reflex control and the role of the autoregulation in the systemic and pulmonary arterial pressure-flow relationships of the dog. Circ Res 1984; 54: 674–82.[Abstract/Free Full Text]

22 Peterson WP, Trempy GA, Nishiwaki K, Nyhan DP, Murray PA. Neurohumoral regulation of the pulmonary circulation during circulatory hypotension in conscious dogs. J Appl Physiol 1993; 75: 1675–82.[Abstract/Free Full Text]

23 Lennon PF, Murray PA. Attenuated hypoxic pulmonary vasoconstriction during isoflurane anesthesia is abolished by cyclooxygenase inhibition in chronically instrumented dogs. Anesthesiology 1996; 84: 404–14.[Medline]

24 Naeije R, Lejeune P, Leeman M, Melot C, Deloof T. Pulmonary arterial pressure-flow plots in dogs: effects of isoflurane and nitroprusside. J Appl Physiol 1987; 63: 969–77.[Abstract/Free Full Text]

25 Eisenkraft JB. Effects of anaesthetics on the pulmonary circulation. Br J Anaesth 1993; 65: 63–78.[Free Full Text]

26 Wetzel RC, Martin LD. Pentobarbital attenuates pulmonary vasoconstriction in isolated sheep lungs. Am J Physiol 1989; 257: H898–903.[Abstract/Free Full Text]

27 Pinsky MR. Cardiopulmonary interactions. The effects of negative and positive pleural pressure changes on cardiac output. In: Dantzker DR (Ed.). Cardiopulmonary Critical Care. Toronto: Grune and Stratton, 1986.

28 Hakim TS, Michel RP, Minami H, Chang HK. Site of pulmonary hypoxic vasoconstriction studied with arterial and venous oclusion. J Appl Physiol 1983; 54: 1298–302.[Abstract/Free Full Text]

29 Sylvester JT, Mitzner W, Ngeow Y, Permutt S. Hypoxic constriction of alveolar and extra-alveolar vessels in isolated pig lungs. J Appl Physiol 1983; 54: 1660–6.[Abstract/Free Full Text]

30 Naeije R, Lejeune P, Leeman M, Melot C, Closset J. Pulmonary vascular responses to surgical chemodenervation and chemical sympathectomy in dogs. J Appl Physiol 1989; 66: 42–50.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Bellezza, F. Kerbaul, L. Roussel, M. Imbert, and C. Guidon
The effect of hypertonic saline dextran solutions on hypoxic pulmonary vasoconstriction in anaesthetised piglets
Eur. Respir. J., October 1, 2002; 20(4): 965 - 971.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerbaul, F.
Right arrow Articles by Aubert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerbaul, F.
Right arrow Articles by Aubert, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS